Research programme: cyclin dependent kinase 4 inhibitors - Kinnate Biopharma
Alternative Names: CDK4 inhibitors - Kinnate BiopharmaLatest Information Update: 08 Apr 2024
At a glance
- Originator Kinnate Biopharma
- Class Antineoplastics; Small molecules
- Mechanism of Action Cyclin-dependent kinase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours